Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
98 results about "Sinus polyp" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
There are two primary types of nasal polyps: ethmoidal and antrochoanal. Ethmoidal polyps arise from the ethmoid sinuses and extend through the middle meatus into the nasal cavity.
Low dose corticosteroid composition
InactiveUS20060193783A1Improve toleranceReduce local irritationOrganic active ingredientsBiocideRecurrent sinusitisChronic sinusitis
The present invention relates to a low dose composition of budesonide suitable for administration of budesonide to mucosal membranes for the management of nasal symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis, perennial non-allergic rhinitis, nasal polyps, as well as prevention of post surgical polyps, chronic sinusitis and recurrent sinusitis comprising budesonide at a therapeutically effective dose of less than 16 mcg and a pharmaceutically acceptable liquid carrier.
Owner:SUN PHARMA INDS
Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
ActiveUS20050239895A1No irritationInhibit deteriorationBiocideOrganic active ingredientsScleritisPhenylacetic acid
An aqueous liquid preparation of the present invention containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid or its pharmacologically acceptable salt or a hydrate thereof, an alkyl aryl polyether alcohol type polymer such as tyloxapol, or a polyethylene glycol fatty acid ester such as polyethylene glycol monostearate is stable. Since even in the case where a preservative is incorporated into said aqueous liquid preparation, the preservative exhibits a sufficient preservative effect for a long time, said aqueous liquid preparation in the form of an eye drop is useful for the treatment of blepharitis, conjunctivitis, scleritis, and postoperative inflammation. Also, the aqueous liquid preparation of the present invention in the form of a nasal drop is useful for the treatment of allergic rhinitis and inflammatory rhinitis (e.g. chronic rhinitis, hypertrophic rhinitis, nasal polyp, etc.).
Owner:SENJU PHARMA CO LTD
Proprietary Chinese medicine for treating rhinitis
The present invention relates to a Chinese patent medicine for effectively curing the diseases of chronic simple rhinitis, hypertrophic rhinitis, allergic rhinitis, atrophic rhinitis and nasal polyp, etc. with obvious therapeutic effect. Said Chinese patent medicine is made up by using 22 Chinese medicinal materials of xanthium fruit, magnolia flower, dahurian angelica root, Chinese lovage root, ligusticum root, white peony root, ginseng and others through a certain preparation process. Said invention can be made into pill preparation, and its cure rate is 91.6%.
Owner:闫改转
Medicine for treating rhinitis and its preparing process
InactiveCN1602906AEasy to useGood treatment effectAerosol deliveryUnknown materialsMedicinal herbsSinusitis
The invention discloses a nasitis curing medicine, using :Siberian cocklebur fruit, radix angelicae formosanae, lily magnolia, mint, and other Chinese medicinal herbs as raw materials, crushing and then frying in sesame oil, then adding in borneol and paraffin to make into spraying agent for use. The invention need not be orally taken, thus convenient to use, and it can directly act on the affected part, having a direct and remarkable curative effect, able to apply to cure various nasitises, nasosinuitises and nasal polyps.
Owner:古双喜
Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
The invention relates to an application of the fusion proteins FP1-FP8 of VEGF receptors on the treatment of the diseases relating to angiogenesis. The diseases relating to the angiogenesis includes autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, vasculitis, systemic sclerosis and other diseases caused by the angiogenesis such as bronchial asthma, obesity, nasal polyps, rhinitis, liver cirrhosis, endometriosis, uterine bleeding, warts, scars and ovarian cysts, etc.
Owner:CHENGDU KANGHONG BIOTECH
Medicine composition for treating nasopharyngitis and preparing method of medicine composition
The invention provides a medicine composition for treating nasopharyngitis. The medicine composition is prepared from, by weight, 5-15 parts of flower buds of lily magnolia, 4-16 parts of siberian cocklour fruits, 2-17 parts of radix angelicae dahuricae, 5-15 parts of small centipeda herb, 6-13 parts of rhizoma chuanxiong, 3-12 parts of purpurea halitium, 2-10 parts of chitosan or chitosan derivatives, 20-30 parts of ethyl alcohol and 100 parts of water. The medicine composition can effectively relieve the swelling degree of the nasal mucosa and reduce nasal polyps and is remarkable in treatment effect on nasopharyngitis, turbid nasal discharge, dysosmia and other diseases.
Owner:史沛现
Pharmaceutical composition for curing rhinitis and preparation method thereof
InactiveCN101537118AAnthropod material medical ingredientsPill deliveryParanasal sinusitisMedicinal herbs
The invention discloses a pharmaceutical composition for curing rhinitis and a preparation method thereof. The pharmaceutical composition is mainly prepared by extracting the following effective components of a dozen of medical materials including magnolia flower, cidcada slough, ptunella spike, moutan bark, cape jasmine, frosythia fruit, liquorice, arctium fruit, peppermint, almond, anemarrhena rhizome, lilyturf root, common reed rhizome, dark plum, Chinese angelica, schizonepta, and the like. The specific active components of the pharmaceutical composition have the effects of warming lung and spleen, clearing away heat and toxic material, promoting Qi and activating blood, excreting dampness to remove nasal discharge and nourishing yin to mositen dryness and have remarkable therapeutic effects of curing various symptoms such as acute and chronic rhinitis, paranasal sinusitis, allergic rhinitis, sicca and atrophic rhinitis and nasal polyp caused by common cold and other reasons.
Owner:BEIJING ZHONGTAI TIANHE SCI & TECH
Traditional Chinese medicine powder for treating nasal polyp
The invention discloses traditional Chinese medicine powder for treating nasal polyp, and relates to a traditional Chinese medicine for treating rhinopathy. The powder mainly consists of stiff silkworm, 75-85 wt% of cocklebur fruit based on weight of stiff silkworm, 55-65 wt% of asarum based on weight of stiff silkworm, 75-85 wt% of flower bud of lily magnolia based on weight of stiff silkworm, 75-85 wt% of calyx melo based on weight of stiff silkworm, 0.5-1.5 wt% of muskone based on weight of stiff silkworm, 80-100 wt% of dried alum based on weight of stiff silkworm, 15-25 wt% of sal ammoniacus based on weight of stiff silkworm and 4.5-5.5 wt% of borneol based on weight of stiff silkworm. The powder provided by the invention can be directly acted on focus, so that not only is nasal polyp treated, but also continuous nasal obstruction and running nose brought by nasal polyp can be eliminated. Therefore, the powder has the advantages of quick effect, safety and reliability and convenience in use.
Owner:宋青春
Natural sea salt nasal irrigation agent
InactiveCN106038588AFits the definitionThe formula is simple and rigorousSenses disorderPharmaceutical delivery mechanismBacteroidesGlycerol
Owner:长春呈实健康实业有限公司
Traditional Chinese medicine composition for treating rhinitis and external paste and preparation method thereof
ActiveCN103933321AGood curative effectLittle side effectsAnthropod material medical ingredientsHydroxy compound active ingredientsSide effectAcute rhinitis
The invention relates to a traditional Chinese medicine composition for treating rhinitis. The traditional Chinese medicine composition is mainly prepared from the following crude drugs: cantharides, rhizoma typhonii, pinellia ternate, bulb of thunberg fritillary, scolopendra, asarum, centipeda minima, sangusis draconis, borneol and musk in a processing manner according to certain parts by weight. The traditional Chinese medicine composition has a good curative effect on treatment of acute rhinitis, chronic rhinitis, adenoidal hypertrophy, nasal polyp, anaphylactic rhinitis and nasosinusitis, and is quick to take effect, short in curative effect, small in side effect, and fewer in used crude drug variety, the recovery rate can be up to 86%, the effective rate can be up to over 97.8%, and the cost is saved. The traditional Chinese medicine composition can be prepared into external paste, such as patches, water aqua, spray or an ointment and the like, and is more convenient to use and carry, and the availability and the curative effect of the composition are further improved.
Owner:李宝亮
Medication for treating rhinitis, and preparation method
InactiveCN1872332ASignificant effectStrengthen the systemAnthropod material medical ingredientsCapsule deliveryHypertrophic rhinitisCurative effect
A Chinese medicine for treating rhinitis, allergic rhinitis, nasal polyp, hypertrophic rhinitis and atrophic rhinitis features that it is composed of the decoction A prepared from 14 Chinese-medicinal materials including ephedra, astragalus root, pueraria root, etc, the decoction B prepared from 10 Chinese-medicinal materials including mint, astragalus root, capejasmine, etc, and the capsules prepared from 11 Chinese-medicinal materials including rehmannia root, earthworm, jujube, etc. Its preparing process is also disclosed.
Owner:李永元
Traditional Chinese medicine powder preparation for treating rhinitis and preparation method thereof
InactiveCN108653388AEfficient removalGood for treating inflammationPowder deliveryHydroxy compound active ingredientsTreatment effectCure rate
The invention relates to a traditional Chinese medicine powder preparation for treating rhinitis. The traditional Chinese medicine powder preparation is composed of the following raw materials by weight: 2 to 17 parts of Fructus Gleditsiae abnormalis, 1 to 13 parts of Flos Magnoliae liliflorae, 2 to 11 parts of dahurian angelica roots, 3 to 15 parts of cocklebur fruit and 1 to 8 parts of borneol.The invention also relates to a preparation method for the traditional Chinese medicine powder preparation used for treating rhinitis. The traditional Chinese medicine powder preparation of the invention has the beneficial effects that the preparation effectively eliminates inflammations in the nose and especially has good treatment effect on the inflammations of nasal polyp; meanwhile, in the process of treatment, the preparation does not stimulate nasal polyp to lead to other symptoms, is safe in treatment, short in treatment period and high in cure rate, and allows rhinitis to hard to recur.
Owner:沈军伟
Method for establishing eosinophilic granulocyte proportion model by utilizing nasal polyp pathological picture
ActiveCN110739051AProportion value is fast and accurateMedical simulationMedical automated diagnosisData setChronic sinusitis
The invention discloses a method for establishing an eosinophilic granulocyte proportion model by utilizing a nasal polyp pathological picture, and the method comprises the following steps: preparingdata, manufacturing nasal polyp into a slide, scanning by using a digital pathological instrument to obtain a WSI picture, and cutting the WSI picture to obtain small pathological pictures; dividing all the small pathological pictures into training set data and test set data according to a set proportion; establishing the eosinophilic granulocyte proportion model; performing training on an ImageNet data set by adopting an Inception V3 model to obtain model parameters, removing the last full connection layer FC of the model, adding a full connection layer FC, wherein only one neuron is arranged in the full connection layer FC, and no activation function is adopted; setting a loss function to employ a mean square error MSE, and setting a learning rate lr. The method is applied to a chronicnasosinusitis nasal polyp pathological auxiliary diagnosis system, and the eosinophilic granulocyte proportion on a pathological picture is rapidly and accurately obtained through learning and training.
Owner:THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIV +1
Traditional Chinese medicine preparation for treating rhinitis
InactiveCN101422564AEasy to useNo side effectsRespiratory disorderPlant ingredientsNasal cavityAntibiosis
Owner:李世鑑
Traditional Chinese medicine composition for treating nasal polyp
InactiveCN105147898AClear efficacyRegulate immunityAnthropod material medical ingredientsInorganic active ingredientsRHODIOLA ROSEA ROOTLicorice roots
The invention discloses a traditional Chinese medicine composition for treating nasal polyp. The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 3-4 parts of white atractylodes rhizome, 2-4 parts of realgar, 6-8 parts of rhizoma nelumbinis, 4-5 parts of ligusticum wallichii, 2-4 parts of cimicifugae foetidae, 7-9 parts of angelica root, 5-6 parts of cocklebur fruits, 13-18 parts of honeysuckle flowers, 1-2 parts of emblic leafflower fruits, 5-6 parts of rhodiola rosea, 2-4 parts of common hogfenneI root, 7-8 parts of polygonum cuspidatum, 12-14 parts of honey-fried licorice root, 2-3 parts of Chinese violet, 1-2 parts of honeycomb, 5-6 parts of rhizoma alismatis, 3-4 parts of radix sophorae flavescentis, 1-2 part of indigo naturalis, 5-8 parts of centipeda minima, 4-6 parts of muskmelon stem, and 2-4 parts of Oxalis corymbosa DC. The traditional Chinese medicine composition is prepared from multiple traditional Chinese medicines including honeysuckle flowers and honey-fried licorice root at certain ratio, is definite in efficacy, and has the effects of freeing nasal orifices, dispelling cold of wet lung, tonifying Qi and strengthening exterior, resisting bacteria and removing toxins, regulating adjusting immunity, and the like, and compared with the traditional treatment method, the traditional Chinese medicine composition has the total effective rate of 98% or above, and the cure rate is high.
Owner:DANGTU COUNTY KEHUI TRADING
Traditional Chinese medicine composition as well as preparation method and application thereof
InactiveCN103961412AThe best combination methodHeavy metal active ingredientsInorganic boron active ingredientsNasal cavityAdditive ingredient
The invention discloses traditional Chinese medicine composition as well as an application thereof to preparation of drugs and hygienic products for treating adenoidal hypertrophy and nasal polyp. The traditional Chinese medicine composition comprises active pharmaceutical ingredients by weight as follows: 5-25 g of honeysuckle flowers, 5-25 g of fructusforsythiae and 5-25 g of baical skullcap roots. The traditional Chinese medicine composition is prepared from the honeysuckle flowers, the fructusforsythiae and the baical skullcap roots by weight, has effects of clearing heat and toxic materials, relieving sore throat and relieving swelling, and can be mixed with pharmaceutically allowableintravenous drip liquids and excipients to be prepared into preparations acceptable for patients. Orthogonal tests confirm that the honeysuckle flowers are 10 g, the fructusforsythiae is 15 g and the baical skullcap roots are 20 g by weight, the decoction time is 30 min, and the antibacterial curative effect of the traditional Chinese medicine composition is best when the PH is 7.5; in-vitro experiments prove that the traditional Chinese medicine composition has good antibacterial and anti-inflammation effects; nasal root instillation or nasal cavity flushing or nasal root smearing clinically proves that the traditional Chinese medicine composition has significant effects on treating the adenoidal hypertrophy and the nasal polyp and is good in safety.
Owner:SHENZHEN RUILAI GUISHENG BIOMEDICAL TECH CO LTD
Traditional Chinese medicine liquid preparation for treating rhinitis and preparation method thereof
ActiveCN103933502APromote blood circulationNo side effectsAnthropod material medical ingredientsHydroxy compound active ingredientsSinusitisPharmaceutical Aids
The invention discloses a traditional Chinese medicine liquid preparation for treating rhinitis and a preparation method thereof. The liquid preparation comprises 500 to 800 parts of main liquid preparation, and several parts of auxiliary components and rice vinegar; wherein the main liquid preparation is prepared by decocting main medicinal raw materials such as radix bupleuri, balloonflower root, herba schizonepetae, coptidis rhizoma, and centipede with water, and the auxiliary components comprise a scallion liquid, a garlic liquid, borneol, and ethanol. The liquid preparation is mainly used to treat rhinitis, nasosinusitis, and nasal polyp, and has the advantages of little using amount, user-friendliness, direct act on nasal mucosa, improvement on the blood circulation of nasal mucosa, rapid absorption, prominent curative effect, no side effect, and no drug resistance. The clinical observation results have shown that the cure rate of 2900 clinical treatments on rhinitis, nasosinusitis, and nasal polyp can reach 84% to 85%.
Owner:陈园创 +1
A rhinitis ointment for external use
ActiveCN102258650ASignificant effectAnthropod material medical ingredientsAerosol deliveryD ointmentGLYCYRRHIZA EXTRACT
The invention belongs to a medicine, in particular to external rhinitis paste researched and developed on the basis of decoction and pills of an oral traditional Chinese medicine for treating rhinitis. The external rhinitis paste is ointment prepared by the steps of drying, baking and breaking sixteen Chinese medicinal materials into 200-mesh powders, adding hawthorn oil and beewax after mixing and uniformly stirring; and the external rhinitis paste comprises the sixteen Chinese medicines in kilogram by weight: 5g of cocklebur fruit, 5g of magnolia flower, 10g of radix angelicae, 5g of honeysuckle flower, 10g of chrysanthemum, 10g of scutellaria baicalensis, 10g of coptis chinensis, 10g of plantain, 10g of platycodon grandiflorum, 10g of Chinese violet, 10g of rhizoma acori graminei, 5g of mint, 10g of red flower, 10g of prunella spike, 10g of oyster, 10g of liquorice, 170g of added hawthorn oil and 20g of beewax. The external rhinitis paste has the effects of dispelling wind and dispersing lung qi, ventilating holes with spice and clearing heat for detoxification, has obvious curative effect on allergic rhinitis, chronic rhinitis, atrophic rhinitis, nasosinusitis, nasal polyp andacute or chronic nasosinusitis, and can cure the rhinitis at one time without recurrence.
Owner:陈晓阳
Medicament for treating coryza and preparation thereof
InactiveCN101322759AUnique curative effectQuick resultsCapsule deliveryRespiratory disorderMedicinal herbsDisease
The invention relates to a traditional Chinese medicine for treating rhinitis diseases, which is made by using Chinese medicinal herbs as raw materials; the traditional Chinese medicine consists of honeysuckle, astragalus root, angelica, hemlock parsley, baikal skullcap root, peach kernel, biond magnolia flower, dahurian angelica, wild chrysanthemum flower, licorice and asarum. The traditional Chinese medicine of the invention is developed based on the patrimonial secret recipe by repeated tests and the summary of years of clinical experiences, therefore, the traditional Chinese medicine has unique efficacy on intractable cardiovascular and cerebrovascular diseases, rhinitis, nasosinusitis and nasal polyp, which has the advantages of being rapid to take effect, short course of treatment, high curative ratio and low expense.
Owner:张景峰
Far infrared ceramic powder nasal patch
InactiveCN106422084AReduces and alleviates obstructive dyspneaReduces and relieves shortness of breathLight therapyNasal cavitySurface layer
The invention discloses a far infrared ceramic powder nasal patch. The far infrared ceramic powder nasal patch comprises a surface layer, an adhesive layer, a far infrared ceramic layer and an exhausting and sweat discharging hole, wherein the surface layer is located at the outermost side; the adhesive layer is located at the inner side of the surface layer; the far infrared ceramic layer is arranged at the inner side of the adhesive layer and the area of the far infrared ceramic layer is smaller than that of the adhesive layer; the far infrared ceramic layer is made of far infrared ceramic powder; the exhausting and sweat discharging hole is formed in the inner side of the far infrared ceramic layer, and an elastic sheet for adjusting the shape of the far infrared ceramic layer is arranged between the far infrared ceramic layer and the adhesive layer. The product disclosed by the invention is convenient to use; the far infrared ceramic powder is heated to send out normal full radiation for treating; the effective time is short and problems that expiratory dyspnea and breathing disorder of obstruction of nasal cavities, caused by nasitis, nasal polyp hyperplasia, nasosinusitis and long-period oxygen inhalation, are reduced and alleviated to the greatest extent; the far infrared ceramic powder nasal patch is especially suitable for teenagers at growth and development phases, has a wide market prospect and has a good utilization effect.
Owner:宋玉明
Method for diagnosis of severity and prediction of recurrence in eosinophilic inflammatory disease
InactiveUS20100138937A1Inhibit progressPrevent relapsePeptide/protein ingredientsMicrobiological testing/measurementAlveolar lavage fluidEosinophilic leukocyte
A method for diagnosis of the severity of a condition in an eosinophilic inflammatory disease such as nasal polyp or for prediction of the recurrence of the disease, the method comprising detecting H-PGDS induced by eosinophilic leukocytes accumulated in a lesion or determining pGD2 in a nasal alveolar lavage fluid or Bronchoalveolar lavage fluid
Owner:AROS ELECTRONICS +1
Nasal polyp pathological section analysis method and system and readable storage medium
PendingCN114240836AImprove diagnostic efficiencyMore accurate classificationImage enhancementImage analysisEpitheliumSinusitis
The invention discloses a nasal polyp pathological section analysis method and system and a readable storage medium, and the method comprises the steps: collecting the pathological image information of an entity section under a microscope in real time through an image collector, and transmitting the information to a processor; the processor is used for performing effective area detection on all cells on the nasal polyp pathological image, removing an epithelium area, a blood vessel area and a gland area in the current visual field, and then counting the number of plasma cells, neutrophils, eosinophils and lymphocytes in the current visual field; counting the sum of the four types of inflammatory cells as the total number of inflammatory cells in the current view; and then calculating the percentage of plasma cells, neutrophil cells, eosinophil cells and lymphocytes, finally judging the nasal polyp inflammation type of the current slice patient according to the number and proportion of the four types of inflammatory cells under the random 10 high-power lens visual fields and hot spot visual fields in the current slide, and finally storing the statistical result. The invention is helpful for individualized diagnosis and treatment and prognosis improvement of nasosinusitis patients.
Owner:杭州迪英加科技有限公司 +1
Rhinitis powder and preparation method thereof
InactiveCN106344748AGood effectGood curative effectPowder deliveryHydroxy compound active ingredientsDiseaseNasion
The invention relates to rhinitis powder and belongs to the technical field of traditional Chinese medicine preparations. Sole horn powder, musk, borneol, camphor, magnolia flower, litsea cubeba, rhizoma arisaematis, astragalus membranaceus, areca-nut and ligusticum chuanxiong hort at a certain ratio are prepared into an external application powder agent. The drug powder can be easily blown into nasal cavity, can reach nasion and fully adhere to the inner wall of the nasal cavity, so that the treatment for various nasal cavity diseases, including, nasosinusitis, prosopantritis, nasal polyp, atrophic rhinitis nasal mucosa, acute rhinitis, chronic rhinitis, anaphylactic rhinitis, and the like, can be realized, the effect is obvious and the cure rate is higher.
Owner:胡德法
Device for cleaning nasal polyps
InactiveCN112120761AReduce surgical treatment timeReduce labor intensitySurgeryNasal passagesNasal polyps
Owner:宁波锐风医疗器械有限公司
Nasal nursing spray
ActiveCN109481429AEffective dissolutionImprove antibacterial propertiesAerosol deliveryBathing devicesNasal cavityDisease
The invention provides a nasal nursing spray, and also provides a use method of the spray. The spray contains the following components by weight percentage: 0.22% of sodium pyruvate, 0.05% of pyruvicacid, 0.05% of preservative, 0.1% of Gemini surfactant, and the balance of physiologic seawater. The nasal nursing spray provided by the invention can effectively dissolve nasal mucus and relieve thesymptoms of snot and nasal congestion, has a relatively strong antibacterial ability, can be used for the nasal rinsing of patients of nasal diseases such as acute and chronic rhinitis, allergic rhinitis, nasal polyp and nasosinusitis, and also can be used for the daily nursing of the nasal cavity, and nasal rinsing after rhinitis operation and chemotherapy.
Owner:广州蓓思语生物科技有限公司
Methods for preventing and/or treating nasal polyps and rhinosinusitis
InactiveUS20140242040A1Avoid developmentEffective preventionBiocidePeptide/protein ingredientsSinusitisImmediate release
The invention is directed to methods for preventing and / or treating nasal polyps. The invention is further directed to methods for preventing and / or treating rhinosinusitus. The invention is further directed to reducing inflammation of the paranasal sinuses. The invention is further directed to methods for preventing and / or treating nasal polyps and / or rhinosinusitis by administering to a subject suffering from such conditions, or at risk of developing such conditions, novel cellular factor-containing solution compositions (referred to herein as “CFS” compositions), including novel immediate-release, targeted-release, and sustained-release (SR) cellular factor-containing solution compositions (referred to herein as “SR-CFS” compositions)
Owner:STEMNION
Composition prescription of external remedy for treating rhinitis
InactiveCN101049333AImprove the environmentEasy to useOrganic active ingredientsRespiratory disorderDiseaseUse medication
Owner:杨麟
Chinese herb medicine solution for treating anal firstula
InactiveCN1126550CSignificant effectLess medicinalPharmaceutical delivery mechanismAluminium/calcium/magnesium active ingredientsPharmacologyChinese herbology
Owner:王俊强
Ointment for treating nasal polyp
InactiveCN102512474AEasy to useNo side effectsOrganic active ingredientsAnthropod material medical ingredientsSide effectCure rate
The present invention discloses an ointment for treating nasal polyp. The ointment comprises the following components: 0.05-0.15g artificial bezoar, 0.05-0.15g artificial musk, 0.1-0.5g scorpion, 0.25-0.75g Herba Centipedae, 0.1-0.5g dry dandelion, 0.2g cooling oil and 0.5g vaseline. a production process comprises the following steps: crushing artificial bezoar, artificial musk, scorpion, Herba Centipedae and dry dandelion into fine powder capable of passing through a sieve with 270 meshes, then taking artificial bezoar, artificial musk, scorpion, Herba Centipedae and dry dandelion with the above ratio, and finally adding cooling oil and vaseline with the proportion, uniformly mixing and packaging. The ointment for treating nasal polyp has the advantages of easy usage, and no toxic and side effect, and the clinical tests of 500 patients show that the cure rate is 100%.
Owner:张敬珍
Carbon dioxide laser therapeutic instrument for removing nasal cavity polyps
InactiveCN111281531AImprove convenienceAvoid breakingInstrument probesSurgical instruments for aspiration of substancesCarbon dioxide laser lightMedical equipment
The invention relates to the technical field of nasal polyp treatment medical equipment, in particular to a carbon dioxide laser therapeutic instrument for removing nasal polyps. The carbon dioxide laser therapeutic instrument comprises a laser therapeutic instrument main body, a control panel is arranged in the middle of the front end face of the laser therapeutic instrument main body; a displayscreen is arranged on the left side of the upper end face of the laser therapeutic instrument main body; rollers are arranged at four corners of the lower end surface of the laser therapeutic instrument main body; a rotating groove is formed in the middle of the upper end surface of the laser therapeutic instrument main body. The advantages are that by additionally arranging extremely-thin pipelines on the two sides of a laser head, tissue fluid and smoke are evacuated in time through the pipelines, it is guaranteed that an operation is conducted smoothly and stably, and the convenience of theoperation is greatly improved; and through the cooperation of a disinfection box and a storage insertion table, the end part of the optical fiber after the experiment operation is effectively and timely stored, disinfected and dried, and the fracture of the optical fiber and the pollution of the laser head are avoided.
Owner:姚夏康
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap